Pancreatic Cancer Research

ResearcherNebraska Medical CenterActive in the last 2 years

Michel M. Ouellette

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-7265-6779; OpenAlex author ID A5102848115; NIH RePORTER profile ID 6875186. Sources: OpenAlex.

Their work

Papers
18 (first author 1, last author 6)
Trials
0
Grants
2
Labs led
1
Collaborators
55
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: 3 papers · 2015: 1 paper · 2016: 3 papers · 2017: 2 papers · 2018: 1 paper, 1 grant · 2019: 1 paper · 2020: 1 paper, 1 grant · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 18

  1. Rac1 GTPase Regulates the SCFβTrCP-Mediated Degradation of Claspin and the Cellular Response of Pancreatic Cancer Cells to Gamma Rays. Last author DOI 10.3390/cancers18121908↗
  2. Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signalling. Co-author DOI 10.1016/j.ebiom.2021.103772↗
  3. The GSK3 kinase and LZTR1 protein regulate the stability of Ras family proteins and the proliferation of pancreatic cancer cells. Last author DOI 10.1016/j.neo.2022.01.002↗
  4. Correction: Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. Last author DOI 10.18632/oncotarget.27450↗
  5. PR55α regulatory subunit of PP2A inhibits the MOB1/LATS cascade and activates YAP in pancreatic cancer cells. Co-author DOI 10.1038/s41389-019-0172-9↗
  6. Cigarette Smoke Induces Stem Cell Features of Pancreatic Cancer Cells via PAF1. Co-author DOI 10.1053/j.gastro.2018.05.041↗
  7. Biological determinants of radioresistance and their remediation in pancreatic cancer. Co-author DOI 10.1016/j.bbcan.2017.02.003↗
  8. Inhibitors of telomerase and poly(ADP-ribose) polymerases synergize to limit the lifespan of pancreatic cancer cells. Last author DOI 10.18632/oncotarget.19410↗
  9. PR55α Subunit of Protein Phosphatase 2A Supports the Tumorigenic and Metastatic Potential of Pancreatic Cancer Cells by Sustaining Hyperactive Oncogenic Signal… Co-author DOI 10.1158/0008-5472.can-15-2119↗
  10. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.6580↗
  11. CXCR2 signaling regulates KRAS(G¹²D)-induced autocrine growth of pancreatic cancer. Co-author DOI 10.18632/oncotarget.6906↗
  12. Rac1 GTPase in pancreatic cancer. First author DOI 10.18632/aging.100804↗
  13. Telomerase inhibitor Imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells. Last author DOI 10.1371/journal.pone.0085155↗
  14. Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation. Last author DOI 10.18632/oncotarget.2500↗
  15. Context-dependent function of the deubiquitinating enzyme USP9X in pancreatic ductal adenocarcinoma. Co-author DOI 10.4161/cbt.29182↗
  16. Nicotine/cigarette smoke promotes metastasis of pancreatic cancer through α7nAChR-mediated MUC4 upregulation. Co-author DOI 10.1038/onc.2012.163↗
  17. Relevance of amyloid precursor-like protein 2 C-terminal fragments in pancreatic cancer cells. Co-author DOI 10.3892/ijo.2012.1553↗
  18. Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras. Co-author DOI 10.1158/1078-0432.ccr-10-2288↗

Grants 2

  1. Rac1 GTPase in tumorigenesis and progression of pancreatic cancer R01CA206444↗
  2. Tissue Core P50CA127297↗

Closest collaborators

The 25 strongest of 55 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Surinder K. Batra · 13 shared papers, 2 shared grants, 2013–2026 · strength 2.02
  2. Ying Yan · 10 shared papers, 2014–2026 · strength 1.21
  3. Parthasarathy Seshacharyulu · 6 shared papers, 2016–2022 · strength 0.58
  4. Neha Chaudhary · 2 shared papers, 2022–2026 · strength 0.56
  5. Satyanarayana Rachagani · 5 shared papers, 2016–2022 · strength 0.35
  6. Chi H. Lin · 4 shared papers, 2014–2022 · strength 0.33
  7. Moorthy Palanimuthu Ponnusamy · 5 shared papers, 2013–2022 · strength 0.32
  8. Katrina M. Burchett · 4 shared papers, 2014–2020 · strength 0.32
  9. Ashley L. Hein · 4 shared papers, 2014–2020 · strength 0.32
  10. Michael Anthony Hollingsworth · 3 shared papers, 1 shared grant, 2011–2018 · strength 0.28
  11. Lynette M. Smith · 3 shared papers, 2016–2022 · strength 0.23
  12. Jesse L. Cox · 2 shared papers, 2014–2022 · strength 0.22
  13. Pankaj Kumar Singh · 1 shared paper, 1 shared grant, 2011–2018 · strength 0.20
  14. Sukhwinder Kaur · 2 shared papers, 2017–2022 · strength 0.18
  15. Maneesh Jain · 2 shared papers, 2017–2022 · strength 0.18
  16. Chitra Palanivel · 1 shared paper, 2022 · strength 0.17
  17. Pranita Atri · 2 shared papers, 2018–2022 · strength 0.17
  18. Geoffrey A. Talmon · 2 shared papers, 2018–2022 · strength 0.17
  19. Rama Krishna Nimmakayala · 2 shared papers, 2018–2022 · strength 0.17
  20. Keith R Johnson · 1 shared grant, 2018 · strength 0.17
  21. Jennifer D. Black · 1 shared grant, 2018 · strength 0.17
  22. Julia A Bridge · 1 shared grant, 2018 · strength 0.17
  23. Michael G Brattain · 1 shared grant, 2018 · strength 0.17
  24. Kenneth H. Cowan · 2 shared papers, 2014–2020 · strength 0.16
  25. Saswati Karmakar · 2 shared papers, 2016–2018 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.